Mizuho Markets Cayman LP Has $218.42 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Mizuho Markets Cayman LP grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 173.2% during the first quarter, HoldingsChannel reports. The institutional investor owned 3,068,500 shares of the company’s stock after buying an additional 1,945,500 shares during the quarter. GE HealthCare Technologies comprises about 11.7% of Mizuho Markets Cayman LP’s investment portfolio, making the stock its largest position. Mizuho Markets Cayman LP’s holdings in GE HealthCare Technologies were worth $218,416,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Western Wealth Management LLC raised its position in shares of GE HealthCare Technologies by 2.4% during the 4th quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock valued at $430,000 after acquiring an additional 125 shares in the last quarter. United Community Bank lifted its stake in GE HealthCare Technologies by 10.2% during the fourth quarter. United Community Bank now owns 1,410 shares of the company’s stock worth $116,000 after purchasing an additional 130 shares during the last quarter. Parkside Financial Bank & Trust boosted its holdings in GE HealthCare Technologies by 3.9% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,567 shares of the company’s stock worth $293,000 after purchasing an additional 134 shares during the period. Quadrant Capital Group LLC boosted its holdings in GE HealthCare Technologies by 1.1% in the fourth quarter. Quadrant Capital Group LLC now owns 12,557 shares of the company’s stock worth $1,030,000 after purchasing an additional 140 shares during the period. Finally, Mount Vernon Associates Inc. MD increased its stake in GE HealthCare Technologies by 0.8% during the first quarter. Mount Vernon Associates Inc. MD now owns 18,165 shares of the company’s stock valued at $1,293,000 after purchasing an additional 144 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 1.0%

GEHC stock opened at $61.41 on Thursday. The stock has a market cap of $27.93 billion, a PE ratio of 14.69, a price-to-earnings-growth ratio of 1.69 and a beta of 0.72. The firm’s 50-day simple moving average is $63.65 and its 200 day simple moving average is $71.46. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter last year, the company posted $1.01 EPS. GE HealthCare Technologies’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s payout ratio is currently 3.35%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on GEHC. Evercore set a $80.00 price target on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Weiss Ratings downgraded shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 15th. Wells Fargo & Company dropped their price objective on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a research note on Thursday, April 30th. Royal Bank Of Canada assumed coverage on shares of GE HealthCare Technologies in a report on Tuesday, June 23rd. They issued an “outperform” rating and a $80.00 target price on the stock. Finally, UBS Group decreased their target price on GE HealthCare Technologies from $69.00 to $67.00 and set a “neutral” rating for the company in a research note on Thursday, July 16th. Ten investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $76.41.

Insider Buying and Selling at GE HealthCare Technologies

In related news, Director Kevin Lobo acquired 10,000 shares of GE HealthCare Technologies stock in a transaction that occurred on Friday, May 22nd. The stock was acquired at an average price of $64.18 per share, with a total value of $641,800.00. Following the completion of the acquisition, the director directly owned 14,363 shares of the company’s stock, valued at $921,817.34. This trade represents a 229.20% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Watkin Phoebe L. Yang bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The stock was bought at an average price of $63.01 per share, with a total value of $63,010.00. Following the transaction, the director directly owned 13,702 shares in the company, valued at $863,363.02. This represents a 7.87% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last quarter, insiders purchased 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is currently owned by insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.